CompletedNCT04030143
Multiple-Dose Aripiprazole Injection: Safety in Adults With Schizophrenia or Bipolarity
About this title
A Trial of Multiple-doses of Aripiprazole in Adults With Schizophrenia or Bipolar 1 Disorder
Read the official source —Medication studyAges 18–64United States
Understand this study
Who was this study for?
Listed age limits: 18 years to 64 years.
- Listed locations
- Little Rock and 18 more locationsSee all locations and recruitment
- Study phase
- Phase 1 / Phase 2This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.
Study information
Study start dateStarted: August 1, 2019
- Recruitment status
- Completed
- Enrollment listed in the registry
- 266
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.
- Sponsor type
- Pharmaceutical company
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Phase 1, Phase 2This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.
- Locations
- United States
- Age range
- From 18 Years to 64 Years
- Official registry ID
- NCT04030143
- Official title
Show the full official title
A Phase 1b, Open-label, Multiple-dose, Randomized, Parallel-arm, Safety, Tolerability, and Pharmacokinetic Trial of Aripiprazole Intramuscular Depot Administered in the Gluteal Muscle in Adult Subjects With Schizophrenia or Bipolar I Disorder
Get this study by email
Recruitment & locations
CompletedLittle Rock · Rogers · Bellflower
16 more locations
- Garden Grove
- Glendale
- Lemon Grove
- Orange
- San Diego
- Torrance
- Hollywood
- Miami Lakes
- Atlanta
- Gaithersburg
- St Louis
- Las Vegas
- Marlton
- Dayton
- Charleston
- Austin
Questions about this study
Who is behind this study?
The study sponsor is Otsuka Pharmaceutical Development & Commercialization, Inc., a pharmaceutical company.
Did this study involve medication?
Yes. The study involved medication, including Aripiprazole.
Who was this study for?
Listed age limits: 18 years to 64 years.
